In the following, we show how Magnetique can be used to prioritize DTU interactions with regulators, and how ERK1/2 (MAPK3, MAPK1) regulation is central to the differential gene programs observed in DCM versus HCM. The gene discussed is MAPK1; the disease is familial dilated cardiomyopathy.